ElenaShagisultanovaMD

PubMed

• 1 citations
  Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
  Elena Shagisultanova, William Gradishar, Pavani Chalasani, Andrew J Brenner, Alison Stopeck, Hannah Parris, Dexiang Gao, Jose Mayordomo, Peter Kabos, Virginia F Borges...> ;Clinical Cancer Research. 2023 Dec 15
• 3 citations
  Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
  Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, Sharon Sams, Lyndsey S Crump, Gregory A Vidal, Virginia F Borges, Peter Kabos, Jennifer R Diamond, Elena Shagisult...> ;NPJ Breast Cancer. 2023 May 20
• 5 citations
  Overall survival is the lowest among young women with postpartum breast cancer.
  Elena Shagisultanova, Dexiang Gao, Eryn Callihan, Hannah J Parris, Betsy Risendal, Lisa M Hines, Martha L Slattery, Kathy Baumgartner, Pepper Schedin, Esther M John, V...> ;European Journal of Cancer. 2022 Jun 1
• 15 citations
  Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
  Aryana R Rasti, Amy Guimaraes-Young, Farrah Datko, Virginia F Borges, Dara L Aisner, Elena Shagisultanova> ;JCO Precision Oncology. 2022 Mar 1
• 3 citations
  Triple targeting of breast tumors driven by hormonal receptors and HER2.
  Elena Shagisultanova, Lyndsey S. Crump, Michelle Borakove, Jessica K. Hall, Aryana R Rasti, Benjamin A Harrison, Peter Kabos, Traci R. Lyons, Virginia F. Borges> ;Molecular Cancer Therapeutics. 2021 Nov 2
• 3 citations
  Moving Towards Targeted Therapies for Triple-Negative Breast Cancer
  Jodi A. Kagihara, Elena Shagisultanova, Anosheh Afghahi, Jennifer R. Diamond> ;Current Breast Cancer Reports. 2021 May 4
• 1 citations
  Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval.
  Ericson Stoen, Jodi A. Kagihara, Elena Shagisultanova, Christine M. Fisher, Andrew Nicklawsky, Peter Kabos, Virginia F. Borges, Jennifer R. Diamond> ;Breast Cancer Research and Treatment. 2021 Feb 24
• 8 citations
  Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study.
  Allison H. West, Hayley Knollman, James Dugan, Donald Hedeker, Elisabeth A Handorf, Sarah M. Nielsen, Lisa Bealin, Lindsay G Goldblatt, Heather Willems, Mary B. Daly, ...> ;Cancer Medicine. 2019 Sep 1
• 30 citations
  Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
  Vladislav Korobeynikov, Michelle Borakove, Yayi Feng, William M. Wuest, Alex B. Koval, Anna S. Nikonova, Ilya G. Serebriiskii, Jonathan Chernoff, Virginia F. Borges, E...> ;Breast Cancer Research and Treatment. 2019 Jun 28
• Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer.
  Jennifer A. Weiss, Anosheh Afghahi, Elena Shagisultanova, Jennifer R. Diamond> ;Oncology. 2018 Oct 17
• 12 citations
  Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition.
  Troy Schedin, Virginia F. Borges, Elena Shagisultanova> ;International Journal of Breast Cancer. 2018 Jun 19
• Triple-negative breast cancer in the elderly.
  Elena Shagisultanova, Jose I. Mayordomo, Anthony D. Elias> ;The Breast Journal. 2017 Nov 1
• 14 citations
  Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer.
  Avital Lev, Safoora Deihimi, Elena Shagisultanova, Joanne Xiu, Amriti R. Lulla, David T. Dicker, Wafik S. El-Deiry> ;Cancer Biology & Therapy. 2017 Sep 8
• 23 citations
  BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.
  Safoora Deihimi, Avital Lev, Michael Slifker, Elena Shagisultanova, Qifang Xu, Kyungsuk Jung, Namrata Vijayvergia, Eric A. Ross, Joanne Xiu, Jeffrey Swensen, Zoran Gat...> ;Oncotarget. 2017 May 23
• 37 citations
  The 21-gene recurrence score assay for node-positive, early-stage breast cancer and impact of RxPONDER trial on chemotherapy decision-making: Have clinicians already d...
  Jagar Jasem, Christine M. Fisher, Arya Amini, Elena Shagisultanova, Rachel Rabinovitch, Virginia F. Borges, Anthony D. Elias, Peter Kabos> ;Journal of the National Comprehensive Cancer Network. 2017 Apr 1
• 3 citations
  Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies
  Linda Overholser, Elena Shagisultanova, Rachel Rabinovitch, Nicole Kounalakis, Jennifer R. Diamond, Christina Finlayson, Christine M. Fisher, Peter Kabos, Anthony D. E...> ;Oncology. 2016 Dec 15
• 36 citations
  EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
  Tim N. Beck, Rachel Georgopoulos, Elena Shagisultanova, David Sarcu, Elizabeth Handorf, Cara Dubyk, Miriam N. Lango, John A. Ridge, Igor Astsaturov, Ilya G. Serebriisk...> ;Molecular Cancer Therapeutics. 2016 Oct 1
• 47 citations
  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
  Elena Shagisultanova, Anna Gaponova, Rashid Gabbasov, Emmanuelle Nicolas, Erica A. Golemis> ;Gene. 2015 Aug 1
• 16 citations
  Issues in interpreting the in vivo activity of Aurora-A
  Elena Shagisultanova, Roland L. Dunbrack, Erica A. Golemis> ;Expert Opinion on Therapeutic Targets. 2015 Jan 14
• 5 citations
  Topoisomerase II gene mutations in tumors and tumor cell lines with microsatellite instability
  Elena Shagisultanova, Zhe Piao, Hai-Ri Li, Sergei Malkhosyan> ;Cancer Letters. 2004 Dec 28
• 39 citations
  Hypersensitivity of Tumor Cell Lines with Microsatellite Instability to DNA Double Strand Break Producing Chemotherapeutic Agent Bleomycin
  Hai-Ri Li, Elena Shagisultanova, Kentaro Yamashita, Zhe Piao, Manuel Perucho, Sergei Malkhosyan> ;Cancer Research. 2004 Jul 15
• 10 citations
  The Matrix Metalloproteinase-21 Gene 572C/T Polymorphism and the Risk of Breast Cancer
  Elena Shagisultanova, Inna Novikova, Yuri S. Sidorenko, George N. Marchenko, Alex Y. Strongin, Sergei Malkhosyan> ;Anticancer Research. 2004 Jan 1
• 2 citations
  Polymorphism of the apolipoprotein E gene and the risk of myocardial infarction
  Olga E. Mustafina, Elena Shagisultanova, I. A. Tuktarova, Elza Khusnutdinova> ;Molekuliarnaia Biologiia. 2002 Nov 1
• 11 citations
  [Endothelial nitric oxide synthase gene minisatellite polymorphism: study in populations of the Volga-Ural region and analysis of associations with myocardial infarct ...
  Olga E. Mustafina, Elena Shagisultanova, Timur R. Nasibullin, I. A. Tuktarova, A. M. Bikmeeva, Poliudova On, Elza Khusnutdinova> ;Genetika. 2001 May 1
• 1 citations
  [Connection of HindIII-polymorphism of the lipoprotein lipase gene with risk of developing myocardial infarct].
  Olga E. Mustafina, Elena Shagisultanova, I. A. Tuktarova, Elza Khusnutdinova> ;Molekuliarnaia Biologiia. 2001 May 1
• Join now to see all

Lectures

• Tucatinib, palbociclib, and letrozole in HR+/HER2+ metastatic breast cancer: Report of phase IB safety cohort. 
  2019 ASCO Annual Meeting - 6/1/2019